154 related articles for article (PubMed ID: 1720011)
1. Management of breast cancer with bone metastases.
Clavel M
Bone; 1991; 12 Suppl 1():S11-2. PubMed ID: 1720011
[No Abstract] [Full Text] [Related]
2. [Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
Wander HE; Kleeberg UR; Essers U; Blossey HC; Nagel GA
Onkologie; 1987 Oct; 10(5):321-3. PubMed ID: 2960938
[No Abstract] [Full Text] [Related]
3. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
[No Abstract] [Full Text] [Related]
4. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
Petru E; Schmähl D
Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of the breast].
Battelli T; Manocchi P; Guistini L; Mattioli R; Ginnetti A
Minerva Med; 1984 Feb; 75(6):227-33. PubMed ID: 6231491
[No Abstract] [Full Text] [Related]
6. [Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study].
Beaufort F; Gölles M
Onkologie; 1984 Jun; 7(3):137-40. PubMed ID: 6205336
[TBL] [Abstract][Full Text] [Related]
7. Longterm remission of multiple brain metastases with tamoxifen.
Pors H; von Eyben FE; Sørensen OS; Larsen M
J Neurooncol; 1991 Apr; 10(2):173-7. PubMed ID: 1716670
[TBL] [Abstract][Full Text] [Related]
8. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.
Gundersen S; Kvinnsland S; Lundgren S; Klepp O; Lund E; Børmer O; Høst H
Breast Cancer Res Treat; 1990 Nov; 17(1):45-50. PubMed ID: 2151369
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Dec; (8):1785-810. PubMed ID: 12603970
[No Abstract] [Full Text] [Related]
10. Adjuvant treatment of breast cancer.
Akerley WL
R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
[No Abstract] [Full Text] [Related]
11. [Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].
Wander HE; Teichmann AT; Cremer P; Wieland H; Kruse B; Nagel GA; Kuhn W; Seidel D
Onkologie; 1985 Apr; 8(2):88-92. PubMed ID: 3158861
[TBL] [Abstract][Full Text] [Related]
12. Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.
Hultborn R; Johansson-Terje I; Bergh J; Glas U; Hallsten L; Hatschek T; Holmberg E; Ideström K; Norberg B; Ranstam J; Söderberg M; Wallgren UB
Acta Oncol; 1996; 35 Suppl 5():75. PubMed ID: 9142972
[No Abstract] [Full Text] [Related]
13. Could aminoglutethimide replace adrenalectomy?
Harris AL
Breast Cancer Res Treat; 1985; 6(3):201-11. PubMed ID: 3912013
[TBL] [Abstract][Full Text] [Related]
14. Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.
Pronzato P; Rubagotti A; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso M; Gallotti P; Monzeglio C; Rosso R
Am J Clin Oncol; 1993 Dec; 16(6):522-5. PubMed ID: 8256770
[TBL] [Abstract][Full Text] [Related]
15. [Progestational agents and bone metastasis in breast cancer].
Leriche N; Bonneterre J
Bull Cancer; 1997 Sep; 84(9):891-4. PubMed ID: 9435812
[TBL] [Abstract][Full Text] [Related]
16. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.
Canney PA; Priestman TJ; Griffiths T; Latief TN; Mould JJ; Spooner D
J Natl Cancer Inst; 1988 Sep; 80(14):1147-51. PubMed ID: 2970555
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal control of disseminated breast cancer].
Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
Sov Med; 1990; (6):94-7. PubMed ID: 2144368
[No Abstract] [Full Text] [Related]
19. Tamoxifen therapy of metastatic breast cancer.
Manni A
J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
[TBL] [Abstract][Full Text] [Related]
20. [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
Onkologie; 1982 Aug; 5 Suppl():34-41. PubMed ID: 6290955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
